• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中VPS35基因D620N突变的频率

Frequency of the D620N mutation in VPS35 in Parkinson disease.

作者信息

Kumar Kishore R, Weissbach Anne, Heldmann Marcus, Kasten Meike, Tunc Sinem, Sue Carolyn M, Svetel Marina, Kostić Vladimir S, Segura-Aguilar Juan, Ramirez Alfredo, Simon David K, Vieregge Peter, Münte Thomas F, Hagenah Johann, Klein Christine, Lohmann Katja

机构信息

Section of Clinical and Molecular Neurogenetics, University of Lübeck, Lübeck, Germany.

出版信息

Arch Neurol. 2012 Oct;69(10):1360-4. doi: 10.1001/archneurol.2011.3367.

DOI:10.1001/archneurol.2011.3367
PMID:22801713
Abstract

OBJECTIVE

To evaluate the frequency and clinical spectrum of the recently identified p.D620N mutation in the VPS35 gene in Parkinson disease (PD) in an international sample.

DESIGN

Genetic analysis by DNA sequencing and detailed clinical and neuropsychiatric assessment as well as neuroimaging in mutation carriers.

SETTING

Tertiary referral centers in Germany, Serbia, Chile, and the United States.

PATIENTS

One thousand seven hundred seventy-four patients with PD.

MAIN OUTCOME MEASURE

Frequency of the p.D620N mutation.

RESULTS

A single mutation carrier was identified. The mutation carrier was a 60-year-old German man who had tremor-dominant PD since the age of 45 years. Longitudinal follow-up over 13 years revealed a disease progression from Hoehn and Yahr stage 1 to 3. There was evidence of mild cognitive impairment on the Montreal Cognitive Assessment. No abnormalities were observed by multimodal neuroimaging. He had a family history consistent with autosomal dominant inheritance. An affected paternal aunt and 3 reportedly unaffected siblings were also found to be mutation carriers.

CONCLUSION

VPS35 mutations are a rare cause of PD in different populations. The clinical phenotype may be indistinguishable from idiopathic PD with the possible exception of an earlier age at onset. Genetic analysis of the extended family revealed incomplete penetrance of the p.D620N mutation.

摘要

目的

在一个国际样本中评估最近在帕金森病(PD)中发现的VPS35基因p.D620N突变的频率和临床谱。

设计

通过DNA测序进行基因分析,并对突变携带者进行详细的临床和神经精神评估以及神经影像学检查。

地点

德国、塞尔维亚、智利和美国的三级转诊中心。

患者

1774例帕金森病患者。

主要观察指标

p.D620N突变的频率。

结果

鉴定出一名单一突变携带者。该突变携带者是一名60岁的德国男性,自45岁起患有震颤为主型帕金森病。13年的纵向随访显示疾病从Hoehn和Yahr 1期进展到3期。蒙特利尔认知评估显示有轻度认知障碍的证据。多模态神经影像学未观察到异常。他有符合常染色体显性遗传的家族史。还发现一名患病的父系姑姑和3名据报道未患病的兄弟姐妹也是突变携带者。

结论

VPS35突变是不同人群中帕金森病的罕见病因。临床表型可能与特发性帕金森病难以区分,可能的例外是发病年龄较早。对大家庭的基因分析显示p.D620N突变存在不完全外显率。

相似文献

1
Frequency of the D620N mutation in VPS35 in Parkinson disease.帕金森病中VPS35基因D620N突变的频率
Arch Neurol. 2012 Oct;69(10):1360-4. doi: 10.1001/archneurol.2011.3367.
2
Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease.空泡蛋白分选 35 号天冬氨酸 620 号天冬酰胺突变在帕金森病的华裔人群中罕见。
Parkinsonism Relat Disord. 2012 Jun;18(5):638-40. doi: 10.1016/j.parkreldis.2012.02.011. Epub 2012 Mar 10.
3
VPS35 mutation in Japanese patients with typical Parkinson's disease.日本典型帕金森病患者中 VPS35 突变。
Mov Disord. 2012 Sep 15;27(11):1413-7. doi: 10.1002/mds.25145. Epub 2012 Sep 18.
4
Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?一个患有帕金森病的德国家庭中纯合子和杂合子PINK1突变的临床谱:单次打击的作用?
Arch Neurol. 2006 Jun;63(6):833-8. doi: 10.1001/archneur.63.6.833.
5
D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.VPS35基因中的D620N突变和EIF4G1基因中的R1205H突变在希腊人群中并不常见。
Neurosci Lett. 2015 Oct 8;606:113-6. doi: 10.1016/j.neulet.2015.08.020. Epub 2015 Aug 20.
6
The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.与帕金森病相关的 Vps35 D620N 突变破坏了 retromer 的货物分拣功能。
Traffic. 2014 Feb;15(2):230-44. doi: 10.1111/tra.12136. Epub 2013 Nov 14.
7
An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.匈牙利散发性帕金森病患者中GBA和VPS35基因突变频率的评估。
Neurosci Lett. 2016 Jan 1;610:135-8. doi: 10.1016/j.neulet.2015.11.001. Epub 2015 Nov 4.
8
EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa.EIF4G1基因R1205H突变和VPS35基因D620N突变在南非帕金森病患者中较为罕见。
Neurobiol Aging. 2014 Feb;35(2):445.e1-3. doi: 10.1016/j.neurobiolaging.2013.08.023. Epub 2013 Sep 27.
9
Parkinson's disease-linked knockin mice manifest tau neuropathology and dopaminergic neurodegeneration.帕金森病相关基因敲入小鼠表现出 tau 神经病理学和多巴胺能神经退行性变。
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5765-5774. doi: 10.1073/pnas.1814909116. Epub 2019 Mar 6.
10
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.葡萄糖脑苷脂酶基因突变携带者帕金森病的外显率。
Neurology. 2012 Feb 7;78(6):417-20. doi: 10.1212/WNL.0b013e318245f476. Epub 2012 Jan 25.

引用本文的文献

1
Dystonia-predominant VPS35-related parkinson's disease: diagnostic challenges and the role of Levodopa response in unmasking genetic etiology.以肌张力障碍为主的VPS35相关帕金森病:诊断挑战及左旋多巴反应在揭示遗传病因中的作用
Neurol Sci. 2025 Aug 26. doi: 10.1007/s10072-025-08437-8.
2
VPS26A as a Prognostic Biomarker and Therapeutic Target in Liver Hepatocellular Carcinoma: Insights from Comprehensive Bioinformatics Analysis.VPS26A作为肝细胞癌的预后生物标志物和治疗靶点:综合生物信息学分析的见解
Medicina (Kaunas). 2025 Jul 16;61(7):1283. doi: 10.3390/medicina61071283.
3
VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress.
VPS35 或 retromer 作为神经退行性疾病的潜在靶点:进展的障碍。
Expert Opin Ther Targets. 2024 Aug;28(8):701-712. doi: 10.1080/14728222.2024.2392700. Epub 2024 Aug 22.
4
Aging, Parkinson's Disease, and Models: What Are the Challenges?衰老、帕金森病与模型:面临哪些挑战?
Aging Biol. 2023;1. doi: 10.59368/agingbio.20230010. Epub 2023 Jul 28.
5
Identification of high-performing antibodies for Vacuolar protein sorting-associated protein 35 (hVPS35) for use in Western Blot, immunoprecipitation and immunofluorescence.鉴定用于蛋白质免疫印迹、免疫沉淀和免疫荧光的液泡蛋白分选相关蛋白35(hVPS35)的高效抗体。
F1000Res. 2023 Oct 16;12:452. doi: 10.12688/f1000research.133696.2. eCollection 2023.
6
The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review.非欧洲裔人群中单基因帕金森病的研究现状:综述。
Genes (Basel). 2023 Nov 17;14(11):2097. doi: 10.3390/genes14112097.
7
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.理解 VPS35 和逆行转运体在神经退行性疾病中的作用。
Neurobiol Dis. 2022 Aug;170:105768. doi: 10.1016/j.nbd.2022.105768. Epub 2022 May 16.
8
The retromer complex regulates C. elegans development and mammalian ciliogenesis.该返回体复合物调节秀丽隐杆线虫的发育和哺乳动物纤毛发生。
J Cell Sci. 2022 May 15;135(10). doi: 10.1242/jcs.259396. Epub 2022 May 17.
9
Mechanisms of -Mediated Neurodegeneration in Parkinson's Disease.帕金森病中α-突触核蛋白介导神经退行性变的机制
Int Rev Mov Disord. 2021;2:221-244. doi: 10.1016/bs.irmvd.2021.08.005. Epub 2021 Sep 30.
10
Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.单基因帕金森病:基因型、表型、病理生理学及基因检测
Genes (Basel). 2022 Mar 7;13(3):471. doi: 10.3390/genes13030471.